17TH EFORT Congress EFORT Congress Deliver your sales ... · Ideal for DCO Ready-to-use sterile kit (no sterilization costs, easy inventory and traceability manage) One Giant Leap

Congress Highlights | Main Theme: Maintaining Activity Through Life

17TH EFORTCongress 2016

www.efort.org/geneva2016

General Orthopaedics Tribology: Bearing Choices Bones and Joints: Replace or Repair Implants & Biomaterials: Is New Safe? The Obese Patient Innovation and Sustainability

Trauma Augmented Implants

Paediatrics Early Care Achieves Life-Time Mobility

Spine Clinical Judgement in the Aged Spine

Upper Limb Hand: The Tool to Care For! Computer Assisted Shoulder Surgery Pitfalls in Rotator Cuff Surgery

Lower Limb Knee Replacements: Expectations and Reality Perioperative Management in TKR Hip Replacements: Expectations and Limits New Approach, New Components, New Problems Cemented or Cementless Degenerative Foot and Ankle

Musculoskeletal Infections Strategies in Infected Implants

Musculoskeletal Tumours Influence of Age on Reconstruction in Bone Tumours

Key datesRegistration opens: 15 September 2015

Early registration deadline: 29 February 2016

Advanced Programme online: 15 March 2016

17TH EFORT Congress A combined programme in partnership with swiss orthopaedicsGeneva, Switzerland: 01-03 June 2016 #EFORT2016

A combined programme in partnership with swiss orthopaedics

































Drive traffic to your booth

Maximize your company and product visibility

Get immediate access to buying decision makers

Deliver your sales message and build booth traffic every day of the congress.

Advertise in the 2016 EFORT Daily NewsReach more than 7,000 orthopaedic and trauma surgeons and healthcare professionals with EFORT Daily News, the only official newspaper of the 17th EFORT Congress. The congress Daily News is reported live on site, printed overnight and distributed each morning to all attendees. It’s the reference attendees need for timely reports on congress activities, including news, session updates, member activities, special events and more.

For details of additional cost benefits during EFORT to those quoted overleaf contact [email protected]

17th EFORT CongressA combined programme in partnership with swiss orthopaedicsGeneva, Switzerland: 01-03 June 2016

DAILY NEWSA SLACK Incorporated® publication16TH EFORT CONGRESS

• Exhibition opens9:00-17:30

• Morning Sessions9:00-10:30

• Industry Expert Lunch Symposium13:00-14:30

EFORT Congress FormatLearn about this year’s format, which features interactive expert exchanges, complex case discussions, debate forums and evidence-based medicine . . . . . . . . . . . . . .page 3

Prague City GuideRead about how this year’s host city is a historical and cultural centre fi lled with architectural treasures to explore . . pages 4-5

Intramuscular Lipomas and Atypical Lipomatous TumoursRetrospective study fi ndings on recurrence rate and distant metastasis in intramuscular lipomas and atypical lipomatous tumours surgically excised . page 6

Revision THA Within 5 Years FindingsOverall survival and failure rates, trends of early failure and predictors of THA revisions through 5-year follow-up using a prospective THA database presented . . . . . . . . . . . . . page 6

Featured Sessions

Schedule of Events

GUPRAGUE

Building on the success of last year’s meet-ing, the 16th annual EFORT Congress in Prague will feature a robust scientifi c programme that

includes symposia and instructional lectures from distinguished speakers, as well as Free Paper submissions from all over the world.

With the help of at-tendee feedback, the Congress programme has been carefully de-veloped to appeal to

both new and experienced physicians. EFORT, in collaboration with European Specialty sSociet-ies in hip, knee, shoulder and elbow, and foot and ankle orthopaedics, has organised highly rated sessions from previous years, as well as the One-day Comprehensive Review Course aimed at younger colleagues and residents, and the Michael Freeman and Erwin Morscher Hon-orary Lectures.

“We know junior physicians appreciate the opportunity to present their early research work, so Free Paper submissions are always very popu-lar, as well as the instructional lectures,” said Stephen R. Cannon, MA, MChOrth, FRCS, MB, BChir, 2014/2015 EFORT president and consul-tant orthopaedic surgeon in the department of orthopaedic surgery at the Royal National Or-thopaedic Hospital, Stanmore, U.K. “Added to which, we have the Advanced Course in hip and knee … and symposia of high clinical standards to foster the interchange of ideas amongst phy-sicians with quite signifi cant knowledge.

“So [EFORT] gives physicians the opportunity

not only to do some interchange with colleagues at a very high level, but also to help the ongo-ing education of more junior and less specialist orthopaedic surgeons in Europe,” he continued. “Everyone will also have the opportunity to meet fellow enthusiasts in all areas of orthopaedic surgery.”

One of the educational highlights from EFORT will be the congress’ main theme of or-thopaedic infection.

“Infection is one of the main complications of elective orthopaedic surgery,” Cannon said.

EFORT welcomes attendees to Prague for 16th EFORT Congress

With its main theme, the 16th annual EFORT Congress in Prague will shine a spotlight on the infrequent, but potentially problematic, phenomenon of orthopaedic infection.

Currently, the average incidence of in-fection caused by total joint arthoplasty is between 3% and 4%, although this rate is generally higher after fracture fi xation. In addition, the rate of deep infection after primary hip replacement varies in literature from 0.28% to 4%.

“Orthopaedic infections are increasing and are increasingly complex to treat due to biofi lms and increased antimicrobial resistance of causing microorganisms,” said Andrej Trampuz, MD, infectious diseases consultant at Charité - University Medicine in Berlin.

Stephen R. Cannon

Orthopaedic infections to take centre stage at 16th EFORT Congress

(Cannon continued on page 5)

(Infections continued on page 7)

™ Designed to avoid contaminationof the medullary canalIdeal for DCOReady-to-use sterile kit (no sterilization costs,easy inventory and traceability manage)

One Giant Leapfor Damage

ControlOrthopaedics

Experience Innovation

Orthofix Extremity Fixation. Experience Passion.

MRI conditionalat 1.5 and 3 Tesla(more details available in relevant Instructions For Use)

Designed for aminimally invasive approachDesigned tofacilitate conversion from temporaryto definitive fixation

Jan A.N. VerhaarAndrej Trampuz

Prague is the host city of the 16th EFORT Congress. A sightseeing guide can be found on page 4.

27 MAY 2015

ote.Healio.com

DAILY NEWSA SLACK Incorporated® publication16TH EFORT CONGRESS

• Exhibition opens9:00-17:30

• Morning Sessions9:00-10:30

• Industry Expert Lunch Symposium13:00-14:30

EFORT Congress FormatLearn about this year’s format, which features interactive expert exchanges, complex case discussions, debate forums and evidence-based medicine . . . . . . . . . . . . . .page 3

Prague City GuideRead about how this year’s host city is a historical and cultural centre fi lled with architectural treasures to explore . . pages 4-5

Intramuscular Lipomas and Atypical Lipomatous TumoursRetrospective study fi ndings on recurrence rate and distant metastasis in intramuscular lipomas and atypical lipomatous tumours surgically excised . page 6

Revision THA Within 5 Years FindingsOverall survival and failure rates, trends of early failure and predictors of THA revisions through 5-year follow-up using a prospective THA database presented . . . . . . . . . . . . . page 6

Featured Sessions

Schedule of Events

GUPRAGUE

Building on the success of last year’s meet-ing, the 16th annual EFORT Congress in Prague will feature a robust scientifi c programme that

includes symposia and instructional lectures from distinguished speakers, as well as Free Paper submissions from all over the world.

With the help of at-tendee feedback, the Congress programme has been carefully de-veloped to appeal to

both new and experienced physicians. EFORT, in collaboration with European Specialty sSociet-ies in hip, knee, shoulder and elbow, and foot and ankle orthopaedics, has organised highly rated sessions from previous years, as well as the One-day Comprehensive Review Course aimed at younger colleagues and residents, and the Michael Freeman and Erwin Morscher Hon-orary Lectures.

“We know junior physicians appreciate the opportunity to present their early research work, so Free Paper submissions are always very popu-lar, as well as the instructional lectures,” said Stephen R. Cannon, MA, MChOrth, FRCS, MB, BChir, 2014/2015 EFORT president and consul-tant orthopaedic surgeon in the department of orthopaedic surgery at the Royal National Or-thopaedic Hospital, Stanmore, U.K. “Added to which, we have the Advanced Course in hip and knee … and symposia of high clinical standards to foster the interchange of ideas amongst phy-sicians with quite signifi cant knowledge.

“So [EFORT] gives physicians the opportunity

not only to do some interchange with colleagues at a very high level, but also to help the ongo-ing education of more junior and less specialist orthopaedic surgeons in Europe,” he continued. “Everyone will also have the opportunity to meet fellow enthusiasts in all areas of orthopaedic surgery.”

One of the educational highlights from EFORT will be the congress’ main theme of or-thopaedic infection.

“Infection is one of the main complications of elective orthopaedic surgery,” Cannon said.

EFORT welcomes attendees to Prague for 16th EFORT Congress

With its main theme, the 16th annual EFORT Congress in Prague will shine a spotlight on the infrequent, but potentially problematic, phenomenon of orthopaedic infection.

Currently, the average incidence of in-fection caused by total joint arthoplasty is between 3% and 4%, although this rate is generally higher after fracture fi xation. In addition, the rate of deep infection after primary hip replacement varies in literature from 0.28% to 4%.

“Orthopaedic infections are increasing and are increasingly complex to treat due to biofi lms and increased antimicrobial resistance of causing microorganisms,” said Andrej Trampuz, MD, infectious diseases consultant at Charité - University Medicine in Berlin.

Stephen R. Cannon

Orthopaedic infections to take centre stage at 16th EFORT Congress

(Cannon continued on page 5)

(Infections continued on page 7)

™ Designed to avoid contaminationof the medullary canalIdeal for DCOReady-to-use sterile kit (no sterilization costs,easy inventory and traceability manage)

One Giant Leapfor Damage

ControlOrthopaedics

Experience Innovation


MRI conditionalat 1.5 and 3 Tesla(more details available in relevant Instructions For Use)

Designed for aminimally invasive approachDesigned tofacilitate conversion from temporaryto definitive fixation

Jan A.N. VerhaarAndrej Trampuz

Prague is the host city of the 16th EFORT Congress. A sightseeing guide can be found on page 4.

27 MAY 2015

ote.Healio.com

DAILY NEWSA SLACK Incorporated® publication16th EFORT CONGRESS

• Incidence of Deep Infection in THA8.00-9.30Helsinki Room

• The Comprehensive Orthopaedic Review Course8.30-18.00London Room

• EFORT Erwin Morcher Honorary Lecture12.30-13.00Prague Room

EFORT Award Winners Highlight Quality Science Winners of the Free Paper Award, Allied Professions Award, Trauma Award, Jacques Duparc Awards are featured. . . . page 4

Short-stem Prosthesis Design Study shows whether short-stem femoral neck preserving total hip arthroplasty led to more favourable biomechanical reconstruction . . . . . . . . page 6

Educational Resources AvailableEFORT.org offers educational courses and EFORT publications. . . . . . . . . . . page 7

Featured Sessions

Schedule of Events

GUPRAGUE

Irrigation and debridement for the treatment of hip and knee periprosthetic joint infections is a reasonable option for selected patients and should be performed within a short interval for

these patients, accord-ing to study results pre-sented here.

“Irrigation and de-bridement for early postoperative and he-matogenous infections is related to unfavour-able outcomes in pa-tients with obesity for total hip arthroplasty, thyroid disease for to-

tal knee arthroplasty, duration of symptoms of more than 5 days for both and infection with methicillin-resistant Staphylococci for both,” Georgios K. Triantafyllopoulos, MD, said at the 16th EFORT Congress.

In a retrospective study, Triantafyllopoulos and colleagues reviewed the clinical charac-teristics of patients who were diagnosed with early postoperative or hematogenous hip and knee periprosthetic joint infections (PJI) and were treated with single or multiple irrigation and debridement procedures between January 2000 and December 2013. Researchers record-ed demographics, infection site and type, dura-tion of symptoms, time from index procedure to irrigation and debridement, pathogen type, comorbidity, interval between serial irrigation and debridements, C-reactive protein levels

and erythrocyte sedimentation rates. The mini-mum follow-up was 12 months. The researchers identifi ed 154 patients with hip and knee (60 hips and 94 knees) PJI. Mean patient age was 64.3 years.

For patients with hip PJI, the success rate of irrigation and debridement was 70%. Re-searchers found obesity (BMI=30) correlated

with failure. Patients who had MRSA infections had 96% lower odds of success compared with patients who had non-Staphylococcal gram positive, gram negative bacteria or negative cultures. Patients with duration of symptoms greater than 5 days had 95.2% lower odds of success. The probability of implant retention decreased by 15.7% for each additional day of symptoms.

For patients with knee PJI, the success rate of

Irrigation and debridement can be viable option for selected patients with periprosthetic joint infections

Orthopaedic surgeons should develop specifi c skills to correctly diagnose traumatic massive rotator cuff tears and ensure these injuries are not missed. Patients who are treated early enough stand the best chances of pain relief and recovery of an accept-able range of motion, according to a presenter at the 16th EFORT Congress.

“The recommendations could be that if you see the patient early, and the patient is active, and you diagnose the patient well, there is no need to wait for the nerve recovery,” Przemyslaw Lubiatowski, MD, of Poznan, Poland, said during a special session organised by the European Society for Surgery of the Shoulder and Elbow.

A late diagnosis — one performed 3 weeks or more post-injury — could prove disabling for a patient, he said.

Degenerative vs traumatic tearsAccording to Lubiatowski, one of the problems in diagnosing

massive rotator cuff tears in patients older than 40 years of age is the traumatic origin of the tear may go undetected. Therefore

Georgios K. Triantafyllopoulos

Diagnose traumatic rotator cuff tears within 3 weeks without waiting for nerve recovery for best patient outcomes

(Triantafyllopoulos continued on page 6)

(Lubiatowski continued on page 6)

Orthofix SymposiumDamage Control in The Lower Limb:The Complete SolutionMay 28th, 1.15-2.45 pm, Room Lisbon, Floor 1

16th EFORT CongressPrague, Czech Republic | 27-29 May 2015


Przemyslaw Lubiatowski

Intervals of more than 20 days between the fi rst and second procedures showed lower odds of success.

28 MAY 2015

ote.Healio.com

DAILY NEWSA SLACK Incorporated® publication16th EFORT CONGRESS

• Advanced Course in Total Hip Replacement8.00-13.00Helsinki Room

• Advanced Course in Total Knee Replacement8.00-13.30Florence Room

• Michael Freeman Honorary Lecture12.30-13.00Prague Room

Paediatric osteoarticular infectionsIn the diagnosis and treatment of paediatric osteoarticular infection, all information should be considered . . . page 3

EFORT 2016 Theme Maintaining Activity Through Life will be the theme of the 17th EFORT Congress in Geneva . . . . . . . . . . . . page 4

Visiting Fellowships, Mark Paterson Travelling Fellowship and Travelling FellowshipEFORT offers three fellowships as an opportunity for young orthopaedic fellows to expand their horizons . . . . . . . . . page 5

Antibacterial hydrogel implant coatingReduced infection rates seen in patients receiving antibacterial hydrogel coated implants . . . . . . . . . . . . . . page 6

Featured Sessions

Schedule of Events

GUPRAGUE

TRAUMAAll that

you needVersatile3 Steps from Trauma Frame to Definitive Hexapod

Ideal for TraumaSimple application on bone in traction Easy access for plastic surgery

Damage ControlWhen definitive circular fixation is the best option

Experience VersatilityCost savingHexapod struts used when really needed

Time savingHexapod conversion without a second surgery


There was 78% eradi-cation of infection in total joint replacement procedures at 3 years follow-up with a simple protocol used by ortho-paedic surgeons at the University of Oxford. These results were com-parable to those with staged revision as an approach to infection treatment, according to data presented at the 16th EFORT Congress.

The protocol consists of debridement, anti-biotics and implant retention (DAIR).

DAIR proved to be cost-effective and was associated with good functional outcomes in patients, William Jackson, BSc, MBBS FRCS(Orth), said.

Comparable to other techniquesBy comparison, washout results for peri-

prosthetic infection range from 26% to 71% infection eradication. “It is only recommended in very acute infections,” Jackson said.

Infection eradication rates for single- and two-stage revision are generally 80% to 90%, he said.

“Probably two-stage is still the gold stan-dard, but there are encouraging results coming out with single-stage revision, particularly in certain situations,” Jackson said.

However, he said patients are not function-ing well following revision procedures. Data from the National Joint Registry of England, Wales and Northern Ireland showed Oxford Knee Scores were 24.9 points following one-stage revision and 22.8 points following two-

stage revision for infection, which indicates limited function.

DAIR: A fi rst option“DAIR depends on your view of the implant

and its viability,” Jackson said.It should be considered as a fi rst option in

patients with infected, but well-fi xed total knee arthroplasty (TKA) implants, but he noted that expert debridement is essential.

“The rationale for this requires a very ag-gressive surgical debridement,” Jackson said.

The procedure takes as long as a primary

joint replacement to complete, patients need 6 weeks of postoperative intravenous antibiotics, depending on the organisms grown from tissue cultures, and 1 year of oral antibiotic therapy.

The Oxford group takes a minimum of six intraoperative samples using separate instru-ments to prevent cross-contamination to deter-mine the patient’s infectious status after DAIR and whether the prosthesis can be retained.

Results with acute infectionIn a study conducted by Jackson and colleagues

Infection treatment option proves effective in joint reconstruction cases, dependent on aggressive debridement

It is time for orthopaedic surgeons to rethink their approach to the diagnosis, treat-ment and management of orthopaedic infections, which are often associated with loose implants and other serious problems for patients, according to a presenter at the 16th

EFORT Congress.“The surgeon always must expect the unexpected,” Heinz Winkler, MD, of Vienna, said.

In today’s environment, “we all know about the biofi lm issue,” he said, noting that orthopaedic surgeons must be familiar with biofi lm therapy and equipped to address nearly any type of infec-tion scenario that affects their patients.

During a session on musculoskeletal infections, Winkler, who is president of the European Bone and Joint Infection Society, said the biofi lm concept is one that will guide the treatment of device-related orthopaedic infections in the future. But, he noted that when it comes to septic revision surgery, it is becoming increas-ingly important for the surgeon to equally consider the control of infection through surgery along with the patient’s postoperative function when making clinical decisions.

William Jackson

Orthopaedists face paradigm shift, new challenges in fi ght against infection

(Jackson continued on page 7)

(Winkler continued on page 7)

Heinz Winkler

29 MAY 2015

ote.Healio.com

One rate secures all 3 issues

Wednesday, 01 June Thursday, 02 June Friday, 03 June

Publisher’s and Representative’s Liability: The Publisher and Advertising Sales Representative will not be liable for any failure to print, publish, or circulate all or any portion of any issue in which an advertisement accepted by the Publisher is contained if such failure is due to war, acts of God, strikes, accidents or any circumstances beyond the Publisher’s control.

Indemnification of Publisher: In consideration of publication of an advertisement, the advertiser and the agency, jointly and separately, will indemnify, defend, and hold harmless the book, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement including, without limitation, claims or suits for libel, violation of right of privacy, copyright infringements, or plagiarism.

Billing Policy: Billing to the advertising agency is based on acceptance by the advertiser of “dual responsibility” for payment if the agency does not remit within 90 days. The Publisher will not be bound by any conditions printed or otherwise, appearing on any insertion order or contract when they conflict with the terms and conditions of this rate card.

Space Reservation: 15 April 2016

Materials Due: 27 April 2016

Reserve your ad space today!Hurry, premium positions are limited.

Size Non-bleed/ Live Area (w x h)

Trim Size (w x h)

Bleed Size (w x h)

4-Color Rate 3 Issues - NET

King page10” x 13” 11” x 14” 11 1/4” x 14 1/4”

14,000 CHF25.4 cm x 33.02 cm 27.94 cm x 35.56 cm 28.575 cm x 36.195 cm

1/2 page (Island)

7 1/2” x 9 3/4” 7 7/8” x 10” 8 1/8” x 10 1/4”9,325 CHF

19.05 cm x 24.765 cm 20.0025 cm x 25.4 cm 20.6375 cm x 26.035 cm

1/4 page (Vertical)

4 23/32” x 5 7/8”5,830 CHF

11.9856 cm x 14.9225 cm

1/8 page (Horizontal)

4 23/32” x 2 7/8”3,500 CHF

11.9856 cm x 7.3025 cm

Premium Positions 4-Color Rate 3 Issues - NET

Cover 4 (Back cover) 21,000 CHF

Cover 2 (Inside front cover) 17,500 CHF

Cover 3 (Inside back cover) 15,750 CHF

Promotional Opportunities

Belly Band 29,000 CHF

Cover Tip 25,650 CHF

Front Page Banner Ad 11,650 CHF

Note: An additional production fee of 300 CHF, will apply to advertisements that change between issues.

15-1

254

Alan ColeBusiness Development ManagerTel +41 21 343 [email protected]

EFORT Head Office ZA La Pièce 21180 RolleSwitzerlandFax +41 21 343 4411www.efort.org

ATTN: Carolyn Boerner SLACK Incorporated 6900 Grove Road Thorofare, NJ 08086-9447 (856) 848-1000 x355 (800) 257-8290 [email protected]

�One rate covers all 3 issues with copy change and targeted messaging for 3 different adverts – one per day.

�Booking this option alongside any other sponsorship opportunity guarantees and secures additional benefits. Ask your sales contact.

Patrick Duffey Vice President, Sales and Marketing Surgery and Related Sciences SLACK Incorporated 6900 Grove Road Thorofare, NJ 08086-9447 (856) 848-1000 x262 (800) 257-8290 [email protected]

For booking, contact: Send materials to:

Documents

17TH EFORT Congress EFORT Congress Deliver your sales ... · Ideal for DCO Ready-to-use sterile kit (no sterilization costs, easy inventory and traceability manage) One Giant Leap